Russian Science Foundation
OrganisationROR
Trials
Collaborator, Early phase 1, Active, not recruiting, 10 people, 4 Oct 2024
Collaborator, Phase 4, Completed, 30 people, 27 Dec 2017
Funded papers
23-15-00124, 3 Oct 2026
22-15-00018, 21 Sept 2026
The Development of Cellular Aging Models Based on AD-MSCs
#25-25-00484, 9 Sept 2026
22-15-00132-P, 5 Sept 2026
Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants
23-14-00348- \u041F, 3 Sept 2026
Berberine and its derivatives as candidate modulators of immunosenescence: a critical evaluation
25-74-31017, 1 Sept 2026
24-45-00032, 30 Aug 2026
26-15-00011, 20 Aug 2026
26–15–00216, 12 Aug 2026
LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome
25-15-00478, 11 Aug 2026
26-19-00667, 7 Aug 2026
25–15-00443, 30 Jul 2026
22-15-00481-П, 28 Jul 2026
Demethyleneberberine alleviates cellular senescence of human fibroblasts by directly activating FEN1
257431017, 18 Mar 2026
The Role of Senescence in the Step-by-Step Development of Endometrial Cancer
24-74-10002, 28 Feb 2026
Multiscale physiologically-based model of age-dependent CD4+ T-lymphocyte homeostasis
23-71-10051, 4 Feb 2026
21 Jan 2026
Age- and Genotype-Associated Specific Expression of IL-1 and TNF Receptors on Immunocompetent Cells
13 Jan 2026
23-15-00443, 29 Dec 2025
Do we actually need aging clocks?
25-71-20017, 19 Dec 2025
Sources: api.crossref.org
Papers
Biomedicines, 27 May 2026
AAIC 2025 abstract, 9 Jan 2026
HAEEPGP Peptide Efficiently Prevents Alzheimer's Disease Pathology in Vivo
AAIC 2025 abstract, 23 Dec 2025